1-3 of 3
Preetesh Jain, MBBS, MD, DM
Close
Sort by
Journal Articles

Causes of Discontinuation and Long-Term Outcomes of Patients with CLL after Discontinuing Ibrutinib

Preetesh Jain, MBBS, MD DM, PhD, Philip A Thompson, MBBS, Michael Keating, MBBS, Zeev Estrov, MD, Alessandra Ferrajoli, MD, Nitin Jain, MD, Hagop M. Kantarjian, MD, Jan Burger, MD PhD, Susan M. O'Brien, MD, William G. Wierda, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4390.
https://doi.org/10.1182/blood.V128.22.4390.4390
Published: 2016
Journal Articles

Elevated IL-17 Producing Cells (Th17 and Non-Th17) In Different CLL Microenvironments: Correlation with Overall Survival, Prognostic Relevance and Phenotypic Heterogenity

Preetesh Jain, MBBS, MD, DM, Mohammad Javadan, PhD, Franziska Feger, Pui Chiu, Stella Stefanova, Rajendra N Damle, PhD, Steven L. Allen, MD, Jonathan E Kolitz, MD, Kanti R Rai, MD, Nicholas Chiorazzi, Barbara Sherry
Journal: Blood
Blood (2010) 116 (21): 2442.
https://doi.org/10.1182/blood.V116.21.2442.2442
Published: 2010
Journal Articles

Th-17/IL-17 Axis in Chronic Lymphocytic Leukemia.

Preetesh Jain, MBBS, MD, DM, Xiao J. Yan, MD, PhD, Mohammad Javdan, PhD, Pui Yan Chiu, MS, Rajendra N Damle, PhD, Tarush Kothari, MD, Steven L Allen, Matthew Kaufman, MD, Jonathan E. Kolitz, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD, Barbara Sherry, PhD
Journal: Blood
Blood (2009) 114 (22): 2357.
https://doi.org/10.1182/blood.V114.22.2357.2357
Published: 2009